Skip to main content

Table 2 Associations between generalised and institutional trust in wave 1 (age 15–16) and depression and anxiety symptoms in wave 3 (age 20–21). Results from binary logistic and linear regression models. n = 2,668

From: Trust in adolescence and depression and anxiety symptoms in young adulthood: findings from a Swedish cohort

 

Depression symptoms (PHQ-2, cutoff ≥ 3), wave 3

 

Crudea

Model 1b

Model 2c

Model 3d

 

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

Generalised trust, wave 1

0.65***

0.53, 0.78

0.79*

0.65, 0.96

  

0.79*

0.64, 0.97

Institutional trust, wave 1

0.76**

0.64, 0.90

  

0.93

0.77, 1.11

0.99

0.82, 1.20

 

Anxiety symptoms (GAD-2, cutoff ≥ 3), wave 3

 

Crudea

Model 1b

Model 2c

Model 3d

 

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

Generalised trust, wave 1

0.70***

0.58, 0.85

0.87

0.71, 1.06

  

0.86

0.69, 1.06

Institutional trust, wave 1

0.80**

0.68, 0.94

  

0.99

0.83, 1.19

1.04

0.86, 1.26

 

Depression and anxiety symptoms (PHQ-4, scale 0–12), wave 3

 

Crudea

Model 1b

Model 2c

Model 3d

 

b

95% CI

b

95% CI

b

95% CI

b

95% CI

Generalised trust, wave 1

-0.81***

-1.05, -0.58

-0.42***

-0.65, -0.19

  

-0.45***

-0.70, -0.20

Institutional trust, wave 1

-0.43***

-0.65, -0.21

  

-0.04

-0.27, 0.18

0.09

-0.15, 0.33

  1. *** p < 0.001 **p < 0.01 *p < 0.05
  2. a Includes one variable at a time, controlling for gender
  3. b Includes generalised trust, gender, parental education, parental country of birth, medication for depression and anxiety, and psychosomatic complaints (all measured in wave 1)
  4. c Includes institutional trust, gender, parental education, parental country of birth, medication for depression and anxiety, and psychosomatic complaints (all measured in wave 1)
  5. d Includes generalised and institutional trust, gender, parental education, parental country of birth, medication for depression and anxiety, and psychosomatic complaints (all measured in wave 1)